COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER

Clinical trial NCT05692024 · RECRUITING

Trial details

NCT number: NCT05692024
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Coffee Gastrointestinal Microbiome Stenosis Fibrosis, Liver Ultrasound Elastography Proton Magnetic Resonance Spectroscopy

Start date: 2024-03-21
Primary completion: 2028-03-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.